Rong Rong Qiang , Yang Xiang , Lei Zhang , Xin Yue Bai , Die Zhang , Yang Jing Li , Yan Ling Yang , Xiao Long Liu
{"title":"Ferroptosis: A new strategy for targeting Alzheimer’s disease","authors":"Rong Rong Qiang , Yang Xiang , Lei Zhang , Xin Yue Bai , Die Zhang , Yang Jing Li , Yan Ling Yang , Xiao Long Liu","doi":"10.1016/j.neuint.2024.105773","DOIUrl":null,"url":null,"abstract":"<div><p>Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a complex pathogenesis, which involves the formation of amyloid plaques and neurofibrillary tangles. Many recent studies have revealed a close association between ferroptosis and the pathogenesis of AD. Factors such as ferroptosis-associated iron overload, lipid peroxidation, disturbances in redox homeostasis, and accumulation of reactive oxygen species have been found to contribute to the pathological progression of AD. In this review, we explore the mechanisms underlying ferroptosis, describe the link between ferroptosis and AD, and examine the reported efficacy of ferroptosis inhibitors in treating AD. Finally, we discuss the potential challenges to ferroptosis inhibitors use in the clinic, enabling their faster use in clinical treatment.</p></div>","PeriodicalId":398,"journal":{"name":"Neurochemistry international","volume":null,"pages":null},"PeriodicalIF":4.4000,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurochemistry international","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0197018624001001","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a complex pathogenesis, which involves the formation of amyloid plaques and neurofibrillary tangles. Many recent studies have revealed a close association between ferroptosis and the pathogenesis of AD. Factors such as ferroptosis-associated iron overload, lipid peroxidation, disturbances in redox homeostasis, and accumulation of reactive oxygen species have been found to contribute to the pathological progression of AD. In this review, we explore the mechanisms underlying ferroptosis, describe the link between ferroptosis and AD, and examine the reported efficacy of ferroptosis inhibitors in treating AD. Finally, we discuss the potential challenges to ferroptosis inhibitors use in the clinic, enabling their faster use in clinical treatment.
阿尔茨海默病(AD)是一种神经退行性疾病,发病机制复杂,包括淀粉样蛋白斑块和神经纤维缠结的形成。最近的许多研究表明,铁蛋白沉积与阿兹海默症的发病机制密切相关。研究发现,与铁变态反应相关的铁超载、脂质过氧化、氧化还原平衡紊乱和活性氧积累等因素导致了AD的病理进展。在这篇综述中,我们探讨了铁蛋白沉积的内在机制,描述了铁蛋白沉积与 AD 之间的联系,并研究了铁蛋白沉积抑制剂治疗 AD 的疗效。最后,我们讨论了在临床中使用铁蛋白沉积抑制剂可能面临的挑战,以便更快地将其用于临床治疗。
期刊介绍:
Neurochemistry International is devoted to the rapid publication of outstanding original articles and timely reviews in neurochemistry. Manuscripts on a broad range of topics will be considered, including molecular and cellular neurochemistry, neuropharmacology and genetic aspects of CNS function, neuroimmunology, metabolism as well as the neurochemistry of neurological and psychiatric disorders of the CNS.